ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,573Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 290

$974K Total Retail Price of All Prescriptions

Rank: 4 out of 290

493 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 8,749 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
ISOSORBIDE MONONITRATE ER 1,112 603 1 9
LISINOPRIL 704 370 2 1
CLOPIDOGREL 650 420 3 11
CRESTOR 638 328 4 16
SIMVASTATIN 542 312 5 5
PLAVIX 505 348 6 12
METOPROLOL SUCCINATE 505 279 6 8
DIGOXIN 461 299 8 13
METOPROLOL TARTRATE 456 244 9 3
POTASSIUM CHLORIDE 342 169 10 14
AMLODIPINE BESYLATE 334 191 11 6
LEVOTHYROXINE SODIUM 322 200 12 31
FUROSEMIDE 316 191 13 4
EFFIENT 263 136 14 39
TRICOR 263 102 14 65
NIASPAN 261 116 16 34
FENOFIBRATE 253 101 17 61
WARFARIN SODIUM 245 134 18 7
CARVEDILOL 240 132 19 2
LOVASTATIN 232 131 20 27
METFORMIN HCL 229 105 21 48
HYDROCODONE-ACETAMINOPHEN 210 134 S3 22 42
LOVAZA 208 88 23 72
RANITIDINE HCL 187 94 24 63
DIOVAN 179 107 25 26
NEXIUM 172 112 26 68
OMEPRAZOLE 171 106 27 29
RANEXA 161 87 28 38
TORSEMIDE 161 107 28 45
ATENOLOL 151 78 30 20
SPIRONOLACTONE 118 70 31 18
NITROSTAT 113 34 32 24
ATORVASTATIN CALCIUM 112 77 33 10
KLOR-CON M20 111 43 34 35
LOSARTAN POTASSIUM 108 95 35 15
LOSARTAN-HYDROCHLOROTHIAZIDE 104 67 36 53
NITROGLYCERIN PATCH 100 58 37 51
PRAVASTATIN SODIUM 95 59 38 17
TRIAMTERENE-HCTZ 94 30 39 49
TRAMADOL HCL 94 49 39 64
SPIRIVA 94 45 39 105
HYDROCHLOROTHIAZIDE 83 42 42 19
BYSTOLIC 81 32 43 30
CITALOPRAM HBR 76 38 44 78
ZOLPIDEM TARTRATE 75 58 45 56
DILTIAZEM HCL 73 40 46 82
CILOSTAZOL 72 33 47 59
DILTIAZEM 24HR CD 71 41 48 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 29 49 41
ZETIA 68 26 50 33
DILTIAZEM ER 68 45 50 43
BENICAR 63 29 52 99
DIOVAN HCT 63 20 52 92
SERTRALINE HCL 61 19 54 89
PANTOPRAZOLE SODIUM 56 36 55 45
NAPROXEN 54 22 56 109
METOLAZONE 52 21 57 95
ENALAPRIL MALEATE 52 47 57 40
ADVAIR DISKUS 50 32 59 99
LIPITOR 50 33 59 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.